Shivanand Lad

Shivanand Lad

Professor of Neurosurgery

Dr. Nandan Lad is a neurosurgeon, scientist, and entrepreneur and Professor and Vice Chair of Innovation for Duke Neurosurgery. He is Director of the Functional & Restorative Neuromodulation Program and the Duke NeuroInnovations Program, a systematic approach to innovation to large unmet clinical needs.

He completed his MD and PhD in Biochemistry at Chicago Medical School and his neurosurgical residency training at Stanford with fellowships in both Surgical Innovation and Functional Neurosurgery.  

Neuromodulation; Neurorestoration; Bioengineering; Medical Device Design; Clinical Trials; Data Science; Health Outcomes.

Appointments and Affiliations

  • Professor of Neurosurgery
  • Faculty Network Member of the Duke Institute for Brain Sciences
  • Core Faculty in Innovation & Entrepreneurship
  • Core Faculty Member, Duke-Margolis Center for Health Policy

Contact Information


  • Stanford University, 2009
  • Stanford University, 2008
  • Stanford University, 2011
  • Stanford University, 2005
  • Ph.D. Rosalind Franklin University of Medicine and Science, 2004
  • M.D. Rosalind Franklin University of Medicine and Science, 2004

Courses Taught

  • NEUROSCI 391: Neuroscience Independent Scholarship 1: Advanced Topics

In the News

Representative Publications

  • Venkatraman, V; Spears, CA; Futch, BG; Yang, LZ; Parente, BA; Lee, H-J; Lad, SP, Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity., Neuromodulation (2023) [10.1016/j.neurom.2023.01.017] [abs].
  • Rajkumar, S; Venkatraman, V; Yang, LZ; Parente, B; Lee, H-J; Lad, SP, Short-Term Health Care Costs of High-Frequency Spinal Cord Stimulation for the Treatment of Postsurgical Persistent Spinal Pain Syndrome., Neuromodulation (2023) [10.1016/j.neurom.2023.01.016] [abs].
  • Neal, CJ; Durning, SJ; Dharmapurikar, R; McDaniel, KE; Lad, SP; Haglund, MM, From Their Eyes: What Constitutes Quality Formative Written Feedback for Neurosurgery Residents., J Surg Educ, vol 80 no. 3 (2023), pp. 323-330 [10.1016/j.jsurg.2022.10.003] [abs].
  • Patel, NP; Wu, C; Lad, SP; Jameson, J; Kosek, P; Sayed, D; Waldorff, EI; Shum, LC; Province-Azalde, R; Kapural, L, Cost-effectiveness of 10-kHz spinal cord stimulation therapy compared with conventional medical management over the first 12 months of therapy for patients with nonsurgical back pain: randomized controlled trial., J Neurosurg Spine, vol 38 no. 2 (2023), pp. 249-257 [10.3171/2022.9.SPINE22416] [abs].
  • Gilligan, C; Volschenk, W; Russo, M; Green, M; Gilmore, C; Mehta, V; Deckers, K; De Smedt, K; Latif, U; Georgius, P; Gentile, J; Mitchell, B; Langhorst, M; Huygen, F; Baranidharan, G; Patel, V; Mironer, E; Ross, E; Carayannopoulos, A; Hayek, S; Gulve, A; Van Buyten, J-P; Tohmeh, A; Fischgrund, J; Lad, S; Ahadian, F; Deer, T; Klemme, W; Rauck, R; Rathmell, J; Maislin, G; Heemels, JP; Eldabe, S; ReActiv8-B Investigators,, Long-Term Outcomes of Restorative Neurostimulation in Patients With Refractory Chronic Low Back Pain Secondary to Multifidus Dysfunction: Two-Year Results of the ReActiv8-B Pivotal Trial., Neuromodulation, vol 26 no. 1 (2023), pp. 87-97 [10.1016/j.neurom.2021.10.011] [abs].